Scotgen Biopharmaceuticals Incorporated
3Patents
0Active
3Granted
30Portfolio score
Filing activity: Mar 8, 1994 → Jun 7, 1995
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5624821A | Antibodies with altered effector functions | Chemistry; Metallurgy | 1,289 | Expired |
| US5648260A | DNA encoding antibodies with altered effector functions | Chemistry; Metallurgy | 1,167 | Expired |
| US5646253A | Recombinant human anti-LK26 antibodies | Physics | 31 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.